Mine Orlu-Gul

479 total citations
14 papers, 338 citations indexed

About

Mine Orlu-Gul is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Mine Orlu-Gul has authored 14 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Geriatrics and Gerontology and 4 papers in Economics and Econometrics. Recurrent topics in Mine Orlu-Gul's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical studies and practices (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Mine Orlu-Gul is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical studies and practices (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Mine Orlu-Gul collaborates with scholars based in United Kingdom, Australia and Türkiye. Mine Orlu-Gul's co-authors include Catherine Tuleu, Fang Liu, Sejal R. Ranmal, Terry B. Ernest, Hannah Batchelor, Talia Flanagan, Sven Stegemann, Mandy Wan, Bahijja Tolulope Raimi‐Abraham and Felicity Smith and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Drugs.

In The Last Decade

Mine Orlu-Gul

14 papers receiving 329 citations

Peers

Countries citing papers authored by Mine Orlu-Gul

Since Specialization

Citations

This map shows the geographic impact of Mine Orlu-Gul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mine Orlu-Gul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mine Orlu-Gul more than expected).

Fields of papers citing papers by Mine Orlu-Gul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mine Orlu-Gul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mine Orlu-Gul. The network helps show where Mine Orlu-Gul may publish in the future.

Co-authorship network of co-authors of Mine Orlu-Gul

This figure shows the co-authorship network connecting the top 25 collaborators of Mine Orlu-Gul. A scholar is included among the top collaborators of Mine Orlu-Gul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mine Orlu-Gul. Mine Orlu-Gul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Meeting commentary–“Parkinson’s disease: From patient to product” 2015 ·International Journal of Pharmaceutics ·(unknown), David Elder, Fang Liu, Carmel Hughes, Mine Orlu-Gul	2
2	Formulation factors affecting acceptability of oral medicines in children 2015 ·International Journal of Pharmaceutics ·Fang Liu, Sejal R. Ranmal, Hannah Batchelor, Mine Orlu-Gul, Terry B. Ernest, (unknown), Talia Flanagan, (unknown), Catherine Tuleu	37
3	Taking the guesswork out of supplying multicompartment compliance aids: do pharmacists require further guidance on medication stability? 2015 ·International Journal of Pharmacy Practice ·Julia Gilmartin‐Thomas, Bahijja Tolulope Raimi‐Abraham, Yogini Jani, Felicity Smith, Mine Orlu-Gul	9
4	Utilization of microfluidic V-junction device to prepare surface itraconazole adsorbed nanospheres 2014 ·International Journal of Pharmaceutics ·İsrafil Küçük, Zeeshan Ahmad, Mohan Edirisinghe, Mine Orlu-Gul	8
5	Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations 2014 ·Drugs ·Fang Liu, Sejal R. Ranmal, Hannah Batchelor, Mine Orlu-Gul, Terry B. Ernest, (unknown), Talia Flanagan, Catherine Tuleu	173
6	Investigation into the dosage form attributes of currently UK licensed cardiovascular and Parkinson's disease drug products 2014 ·International Journal of Pharmaceutics ·Sara M. Hanning, (unknown), Mine Orlu-Gul	3
7	Novel encapsulation systems and processes for overcoming the challenges of polypharmacy 2014 ·Current Opinion in Pharmacology ·Mine Orlu-Gul, (unknown), (unknown), Suntharavathanan Mahalingam, Mohan Edirisinghe	11
8	Multi-compartment compliance aids (MCAs): Application to the geriatric community 2014 ·European Geriatric Medicine ·(unknown), Bahijja Tolulope Raimi‐Abraham, Julia Gilmartin‐Thomas, Mine Orlu-Gul	7
9	Public engagement workshop: How to improve medicines for older people? 2013 ·International Journal of Pharmaceutics ·Mine Orlu-Gul, Bahijja Tolulope Raimi‐Abraham, Elizabeth Jamieson, Li Wei, Macey L. Murray, Katarzyna Stawarz, Sven Stegemann, Catherine Tuleu, Felicity Smith	19
10	Modeling the Physiological Factors That Affect Drug Delivery from a Nipple Shield Delivery System to Breastfeeding Infants 2013 ·Journal of Pharmaceutical Sciences ·(unknown), Mine Orlu-Gul, Catherine Tuleu, Nigel K.H. Slater	11
11	Blinding in pharmacological trials: the devil is in the details 2013 ·Archives of Disease in Childhood ·Mandy Wan, Mine Orlu-Gul, (unknown), Catherine Tuleu	27
12	Meeting commentary—“Medicines for older adults: Learning from practice to develop patient centric drug products” 2013 ·International Journal of Pharmaceutics ·(unknown), Sven Stegemann, Mine Orlu-Gul	14
13	A new reconstitutable oral paediatric hydrocortisone solution containing hydroxypropyl-β-cyclodextrin 2012 ·Drug Development and Industrial Pharmacy ·Mine Orlu-Gul, (unknown), (unknown), Hardyal Gill, Catherine Tuleu	16
14	Time to strengthen the evidence base for paediatric formulations 2011 ·Aston Publications Explorer (Aston University) ·Daniel Kirby, Urvashi Shah, Mine Orlu-Gul, Catherine Tuleu, Tony Nunn, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact